These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 714359)
1. [Treatment of sclerotic macular dystrophy]. Smidovich LE Oftalmol Zh; 1978; (6):471. PubMed ID: 714359 [No Abstract] [Full Text] [Related]
2. [Taufon and emoksipin in the combined treatment of sclerotic macular dystrophies]. Shpak NI; Naritsyna NI; Konovalova NV Oftalmol Zh; 1989; (8):463-5. PubMed ID: 2636345 [TBL] [Abstract][Full Text] [Related]
3. [Use of Soviet-made cytochrome C in sclerotic macular dystrophies]. Kerova IK; Lebekhov PI Vestn Oftalmol; 1978; (2):49-52. PubMed ID: 207001 [No Abstract] [Full Text] [Related]
4. [Dicinon in the treatment of arteriosclerotic macular dystrophy]. Korneva TS Oftalmol Zh; 1980; 35(5):300-2. PubMed ID: 7422220 [No Abstract] [Full Text] [Related]
5. [The retinal pigment epithelium in patients with sclerotic macular dystrophy before and after transection of the superficial temporal artery]. Shilkin GA; Mironova EM; Kuman IG; Katlitskiĭ IuA; Kalinnikov IuIu Vestn Oftalmol; 1989; 105(5):44-7. PubMed ID: 2595899 [TBL] [Abstract][Full Text] [Related]
6. [Characteristics of ocular hemodynamics in patients with sclerotic macular dystrophies and its changes after therapy]. Cherkasov IS; Shibinskaia NI; Novik AIa; Nakhabina TP; Soldatova AM Oftalmol Zh; 1987; (8):482-5. PubMed ID: 3444582 [No Abstract] [Full Text] [Related]
7. [Retinal function under conditions of artificial illumination with varying spectral makeup in patients with sclerotic macular dystrophy]. Soldatova AM Oftalmol Zh; 1990; (7):403-8. PubMed ID: 2092256 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between general state of the body and clinical course of sclerotic macular dystrophy]. Umovist NM Vrach Delo; 1976 Jun; (6):116-9. PubMed ID: 969443 [No Abstract] [Full Text] [Related]
9. [Comparative evaluation of conservative treatment and argon laser coagulation in post-extraction macular dystrophy]. Semenov AD; Romashenkov FA; Pankova OP; Kishkina VIa Oftalmol Zh; 1981; 36(4):211-3. PubMed ID: 7197767 [No Abstract] [Full Text] [Related]
12. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Richer S; Devenport J; Lang JC Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338 [TBL] [Abstract][Full Text] [Related]
13. [Phosphaden in the treatment of patients with age-related macular dystrophies]. Smoliakova GP; Cherepanova GI Oftalmol Zh; 1984; (8):489-91. PubMed ID: 6531176 [No Abstract] [Full Text] [Related]
14. [Campimetry with color filters for the diagnosis of subclinical forms of central retinal sclerotic dystrophy]. Cherkasov IS; Shpak NE Oftalmol Zh; 1989; (8):455-6. PubMed ID: 2636342 [TBL] [Abstract][Full Text] [Related]